Join CEO Evan Levine in a private meeting to discuss the latest developments of PsyBio Therapeutics.

Evan Levine is an assertive and insightfulleader encompassing over three decades of in-depth expertise in biotechnologyand drug development, executive supervision, strategic ventures, assetmanagement and the institutional investment business.

With vast experience managing a multitude of businesses, Evan built PsyBio’s team with experience in mind, curating a team of experts in drug discovery based on synthetic biology, metabolic engineering as well as clinical and regulatory expertise progressing drugs through human studies and regulatory protocols.


Evan assisted in co-founding the company as well as acquiring the key platform technology, funding and institutional round led by the US venerated health care funds and taking the company public on the Toronto Venture Exchange. He continues to support this company’s growth with vigor.